BIOMERICA INC (BMRA)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · BMRA
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -73.7% |
| Our one-year growth estimate | diamond |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| 22.4% |
Growth built into the price is above our model estimate.
The price assumes 96.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Elevated risk of a next-quarter earnings miss: this name is a smaller-cap name (higher miss base rate) and has been missing across recent quarters. A fundamental tilt, not a price call.
Model as of 2026-11-05 · Compared with 43 industry peers · Company calendar date is not available
BMRA — officer change
Dated 2026-10-15
Director — David Moatazedi: A director voluntarily chose not to stand for re-election at the upcoming annual meeting, which is a standard board turnover event without indication of dispute or distress.
Why it matters: BMRA is still losing money, and management lists better operating income as a priority. A smaller loss would show progress on that goal.
Supportive ifThe next reported operating loss is smaller than in the same period before. Or operating income turns positive.
Worry ifThe next reported operating loss is larger than in the same period before.
Why it matters: Director David Moatazedi chose not to stand for re-election. The annual meeting will show who takes the seat and whether the board changes.
Watch forThe annual meeting names a new director and filings confirm the board seat is filled.
Also watch forThe annual meeting ends without naming a replacement. Or a later filing shows the seat is still open.
Why it matters: The deal brings in equity investors, including B. Riley Principal Capital. Its terms and share sales show how much funding BMRA gets and how many shares it issues.
Watch forA later filing shows the placement brings in cash on disclosed terms, with no added share sales beyond those terms.
Also watch forA later filing shows more share sales or dilution than the disclosed placement terms. Or the deal fails to provide the stated funding.
Why it matters: Revenue growth is a stated management priority. Higher sales would show progress, while lower sales would point the other way.
Watch forThe next report shows revenue higher than the same period a year earlier.
Also watch forThe next report shows revenue lower than the same period a year earlier.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$233 on $10,000 · ±2.3% | How much price usually moves either way. |
| Bad day | $529 loss on $10,000 · 5.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $4,826 loss on $10,000 · 48.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.